Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

BIO - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$9.71B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bio-Rad Laboratories Inc. - Ordinary Shares - Class ABio-Rad Laboratories Inc. - Ordinary Shares - Class A9.6-13%3.80.2
$380.00

Target Price by Analysts

5.5% upsideBio-Rad Laboratories Target Price DetailsTarget Price
$149.38

Current Fair Value

58.5% downside

Overvalued by 58.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$9.71 Billion
Enterprise Value$10.66 Billion
Earnings per Share$27.87
Beta1.06
Outstanding Shares26,780,000

Return

Return on Equity13.45%ROE
Return on Assets9.49%
Return on Invested Capital4.03%

Valuation & Multiples

P/E Ratio9.6P/E Ratio
PEG-4.1PEG
Price to Sales3.75Price to Sales
Price to Book Ratio1.27Price to Book Ratio
Enterprise Value to Revenue4.11
Enterprise Value to EBIT26.94
Enterprise Value to Net Income10
Total Debt to Enterprise0.13
Debt to Equity0.19Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 4, 2026
EPS
$2.65
Est. $2.23
Revenue
$656.40 M
Est. $649.94 M

Next Earnings Call

Expected Date
February 11, 2027
EPS Estimate
$2.83
Consensus analyst estimate
Revenue Estimate
$688.66 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.23, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.2286▲ 11.14%
Total Calls3,500▼ 93.16%
Total Puts800▼ 86.67%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %57.45%▼ 15.85%
Total Invested$5.80B▲ 0.83%
Investors Holding330▼ 79.00%

About Bio-Rad Laboratories Inc.

7,450 employees
CEO: Norman Schwartz

Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and ...

Bio-Rad Laboratories Insider Information FAQ

Stockcircle tracks 10 top investors with a current 13F position in Bio-Rad Laboratories. Notable holders include Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 4 top investors increased or opened positions and 5 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle lists 1 politician trade disclosure tied to Bio-Rad Laboratories in the last twelve months, drawn from periodic financial disclosure reports. 1 politician traded Bio-Rad Laboratories in the past year.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.